Back
Range Cancer Therapeutics ETF Vs. TransMedics Group Industry Stock Comparison
Sell
34
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.92
Seasonality Move:
-0.36%
Buy
65
TMDX
TransMedics Group
Last Price:
159.11
Seasonality Move:
12.72%
Sell
34
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.07. The Score for CNCR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
TransMedics Group (TMDX)
is a Buy
Is TransMedics Group a Buy, Sell or Hold?
- The current TransMedics Group [TMDX] share price is $159.14. The Score for TMDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- TMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.07
The current trend is moderately bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
TMDX Stock Price Chart
What is TransMedics Group's stock price today?
-
The TransMedics Group share price today is $159.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 49.96 | Sell |
Chaikin Money Flow: | -1883 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.68 - 15.58) | Sell |
Bollinger Bands (100): | (13.96 - 15.36) | Buy |
TMDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 53.07 | Buy |
Chaikin Money Flow: | 1647554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (144.71 - 167.33) | Buy |
Bollinger Bands (100): | (136.45 - 160.09) | Buy |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.24 | Sell |
20-day SMA: | 15.16 | Sell |
50-day SMA: | 14.84 | Buy |
200-day SMA: | 14.83 | Buy |
8-day EMA: | 15.16 | Sell |
20-day EMA: | 15.14 | Sell |
50-day EMA: | 14.92 | Buy |
200-day EMA: | 14.48 | Buy |
TMDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 156.82 | Buy |
20-day SMA: | 152.14 | Buy |
50-day SMA: | 155.84 | Buy |
200-day SMA: | 116.53 | Buy |
8-day EMA: | 154.32 | Buy |
20-day EMA: | 154.91 | Buy |
50-day EMA: | 153.28 | Buy |
200-day EMA: | 123.8 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
TransMedics Group Earnings Growth & TMDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.19 per share, an increase this year of $1.86 per share, and an increase next year of $0.61 per share.
Range Cancer Therapeutics ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
TransMedics Group Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |